GLAXOSMITHKLINE PLC
GLAXF
| $22.9
|
|
Health Technology
(0.0% 1d) (8.0% 1m) (22.3% 1y) (0.0% 2d) (1.9% 3d) (4.1% 7d) (673.55% volume)
http://gsk.com
Sec Filling | Patents | n/a employees
GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
add to today's watch list email alert is off
brands hepatitis infectious disease respiratory vaccine battery batteries pain relief gastrointestinal skin
Press-releases
BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
LLY | $250.28 |
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
AMRX | $4.61 |
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
MRTX | $118.45 |
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
GILD | $71.91 |
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
GLAXF | $22.9 |
|
Health Technology
|
| O: -1.67%
H: 3.62%
C: 3.62%
PPG | $165.915 |
|
Process Industries
|
| O: -2.07%
H: 0.0%
C: 0.0%
AMGN | $230.86 |
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
PHAT | $14.8 |
|
Health Technology
|
| O: -3.08%
H: 0.0%
C: 0.0%
JNJ | News | $168.61 |
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
GSK | $45.29 |
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
space spac
41% of Growth to Originate from North America for Microbial Products Market |Evolving Opportunities with bioMerieux SA, GlaxoSmithKline Plc & Kyowa Hakko Bio Co. Ltd. |17000+ Technavio Reports
Published: 2022-01-13 (Crawled : 05:00) - prnewswire.com
NVS | $90.4 |
|
Health Technology
|
| O: 1.31%
H: 0.0%
C: 0.0%
TMO | News | $594.8 |
|
Health Technology
|
| O: 0.69%
H: 0.19%
C: -3.81%
SNY | News | $51.51 |
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
SNYNF | News | $104.92 |
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
GSK | $45.29 |
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
america growth
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
SNYNF | News | $104.92 |
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
GSK | $45.29 |
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
VIR | $38.7 |
|
Health Technology
|
| O: 1.05%
H: 1.98%
C: -6.88%
SNY | News | $51.51 |
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
XNCR | $37.05 |
|
Health Technology
|
| O: 0.38%
H: 1.12%
C: -1.31%
covid-19 treatment fda application covid authorization merge
Global End Stage Renal Disease Market 2021-2027: Low Maintenance Dialysis Equipment and Artificial Kidneys are Expected to Drive Market Growth
Published: 2022-01-11 (Crawled : 17:00) - prnewswire.com
MDT | News | $108.105 |
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: 0.0%
SNY | News | $51.51 |
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
GLAXF | $22.9 |
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
AMGN | $230.86 |
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
NVS | $90.4 |
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
SNYNF | News | $104.92 |
|
Health Technology
|
| O: -3.41%
H: 5.99%
C: 1.1%
GSK | $45.29 |
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
BMY | $64.93 |
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply of Sotrovimab, Authorized for the Early Treatment of COVID-19
Published: 2022-01-11 (Crawled : 12:30) - globenewswire.com
GLAXF | $22.9 |
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
Global Depression Drugs Market to Surpass US$ 15,379.0 Million by 2028, Says Coherent Market Insights
Published: 2022-01-07 (Crawled : 19:00) - prnewswire.com
PFE | $54.98 |
|
Health Technology
AZNCF | $118.1 |
|
Health Technology
SNYNF | News | $104.92 |
|
Health Technology
TAK | $14.75 |
|
Health Technology
SNY | News | $51.51 |
|
Health Technology
LLY | $250.28 |
|
Health Technology
GLAXF | $22.9 |
|
Health Technology
GSK | $45.29 |
|
Health Technology
AZN | News | $58.2 |
|
Health Technology
JNJ | News | $168.61 |
|
Health Technology
drug depression
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
GLAXF | $22.9 |
|
Health Technology
|
| O: -2.58%
H: 1.2%
C: 0.05%
LEGN | $41.5 |
|
Health Technology
|
| O: -7.55%
H: 3.65%
C: 3.07%
AMGN | $230.86 |
|
Health Technology
|
| O: -0.64%
H: 0.67%
C: 0.01%
GILD | $71.91 |
|
Health Technology
|
| O: -0.96%
H: 0.58%
C: -0.12%
XLO | $14.52 |
|
Professional, Scientific, and T...
|
| O: 0.33%
H: 5.33%
C: -4.47%
GSK | $45.29 |
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
FATE | $43.28 |
|
Health Technology
|
| O: -0.56%
H: 2.27%
C: -4.25%
AKRO | $22.26 |
|
Health Technology
|
| O: -0.35%
H: 4.23%
C: 3.03%
era therapeutics
Global Hepatorenal Syndrome Treatment Market Research Report (2021 to 2026) - by Type, Treatment, End-user and Region
Published: 2022-01-04 (Crawled : 21:00) - prnewswire.com
GLAXF | $22.9 |
|
Health Technology
|
| O: 0.57%
H: 1.57%
C: 0.28%
MDT | News | $108.105 |
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
BDX | News | $260.975 |
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNY | News | $51.51 |
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
SNYNF | News | $104.92 |
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
JNJ | News | $168.61 |
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
GSK | $45.29 |
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
BAX | News | $85.74 |
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
CPIX | $3.99 |
|
Health Technology
|
| O: -13.36%
H: 0.0%
C: 0.0%
EW | $118.26 |
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
LJPC | $4.92 |
|
Health Technology
|
| O: 0.21%
H: 4.19%
C: -6.06%
BIVI | $4.47 |
|
Health Technology
|
| O: 2.86%
H: 12.1%
C: 12.1%
treatment renal research
Global Drug Delivery Devices Market Research Report (2021 to 2026) - by Route of Administration, Vehicles, Application, End-user and Region
Published: 2022-01-04 (Crawled : 17:00) - prnewswire.com
GLAXF | $22.9 |
|
Health Technology
|
| O: -3.82%
H: 1.65%
C: 0.04%
BDX | News | $260.975 |
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MMM | $178.74 |
|
Producer Manufacturing
|
| O: 0.1%
H: 0.0%
C: 0.0%
SNY | News | $51.51 |
|
Health Technology
|
| O: -2.03%
H: 0.0%
C: 0.0%
OSUR | $8.51 |
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
ATRS | $3.57 |
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: -2.51%
PANA | $9.731 |
|
Finance
|
| O: 0.72%
H: 0.0%
C: -0.72%
JNJ | News | $168.61 |
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
GSK | $45.29 |
|
Health Technology
|
| O: -0.23%
H: 0.62%
C: -0.07%
BAX | News | $85.74 |
|
Health Technology
|
| O: 0.13%
H: 1.18%
C: 1.17%
WST | $379.78 |
|
Health Technology
|
| O: -0.79%
H: 0.66%
C: -3.03%
PHG | News | $34.11 |
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
ABT | News | $130.53 |
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
PODD | $242.71 |
|
Health Technology
|
| O: 2.92%
H: 2.2%
C: -1.17%
application ces drug device research liver vehicles drug delivery
Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Directors
Published: 2021-12-27 (Crawled : 22:00) - biospace.com/
GSK | $45.29 |
|
Health Technology
|
| O: 0.39%
H: 0.43%
C: 0.36%
BVXV | $1.66 |
|
Health Technology
|
| O: -17.63%
H: 2.62%
C: 1.75%
GLAXF | $22.9 |
|
Health Technology
|
| O: 5.52%
H: 0.0%
C: -4.05%
vaccine
Last 15 days Sec forms
| File Id | Form | Date | Direction | Code | Amount Transacted | Owned Amount |